Key clinical point: As cardiovascular risk predictors, troponin and coronary calcium have complementary value and function best together.
Major finding: The rates of ASCVD at 10 years were 2.4% when both biomarkers were negative but up to 9.8% when one was positive.
Data Source: Longitudinal cohort study of 6,749 participants in the Multi-Ethnic Study of Atherosclerosis, with a median 15 years of follow-up.
Disclosures: The senior investigator, Dr. Jaffe, has consulting relationships with many pharmaceutical companies.
Sandoval Y et al. J Am Coll Cardiol. 2020;76:357-70.